Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

Study Identifier
P18-835
CT.gov Identifier
NCT03894956
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Dermatology - Hidradenitis Suppurativa (HS)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    0 - 99 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Participants who have been prescribed Humira by their treating physician as per routine clinical practice for the treatment of HS.
    Exclusion Criteria:
    * Participants previously treated with Humira. * Participants who do not provide consent.

    Protocol Summary

    The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.

    Study Locations

    Location
    Status
    Location
    Anjou Kousei Hospital /ID# 216741
    Anjo-shi, Aichi-ken, Japan, 446-8602
    Status
    Not applicable
    Location
    Ichinomiya Municipal Hospital /ID# 214086
    Ichinomiya-shi, Aichi-ken, Japan, 491-8558
    Status
    Not applicable
    Location
    Aichi Medical University Hospital /ID# 215312
    Nagakute-shi, Aichi-ken, Japan, 480-1195
    Status
    Not applicable
    Location
    NHO Nagoya Medical Center /ID# 214406
    Nagoya, Aichi-ken, Japan, 460-0001
    Status
    Not applicable
    Location
    Nagoya University Hospital /ID# 214135
    Nagoya, Aichi-ken, Japan, 4668560
    Status
    Not applicable
    Location
    Kimitsu Chuo Hospital /ID# 214733
    Kisarazu-shi, Chiba, Japan, 292-8535
    Status
    Not applicable
    Showing {first} - {last} of {total} Results